GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

LONDON - On Wednesday, GlaxoSmithKline plc (NYSE: NYSE:GSK ... below the £0.49 analysts were expecting. The company's top-line performance was driven by continued growth in its Specialty ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that APRETUDE (cabotegravir ...

Farther Finance Advisors LLC decreased its holdings in shares of GSK plc (NYSE:GSK – Free Report) by 27.4% during the fourth ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...

In this article, we are going to take a look at where GSK plc (NYSE:GSK) stands against other best weight loss drug stocks to buy according to analysts. Global Surge in Obesity Medication Market ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of GSK plc, a global healthcare company dedicated to leveraging science, technology, and talent to address disease challenges worldwide.

GlaxoSmithKline Limited (GSK) in Kenya has officially changed its legal entity name to Haleon Kenya Limited. Haleon ...

Shares of GSK PLC GSK slipped 1.73% to £15.05 Wednesday, on what proved to be an all-around positive trading session for the ...